Round table discussion: The clinician's view on outcome methodologies for pharmacologic trials in mild, moderate, and severe Alzheimer's disease

A. L. Mina Bergem; A. Burns; S. Eriksson; S. Finkel; S. Gauthier; R. Levy; L. Mallery; B. Reisberg; L. Schneider; R. Billington

doi:10.1017/S1041610296002694

Round table discussion: The clinician's view on outcome methodologies for pharmacologic trials in mild, moderate, and severe Alzheimer's disease

A. L. Mina Bergem, A. Burns, S. Eriksson, S. Finkel, S. Gauthier, R. Levy, L. Mallery, B. Reisberg, L. Schneider, R. Billington

Medicine

Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	335-342
Number of pages	8
Journal	International Psychogeriatrics
Volume	8
Issue number	2
DOIs	https://doi.org/10.1017/S1041610296002694
Publication status	Published - 1996

ASJC Scopus Subject Areas

Clinical Psychology
Gerontology
Geriatrics and Gerontology
Psychiatry and Mental health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1017/S1041610296002694

Cite this

Mina Bergem, A. L., Burns, A., Eriksson, S., Finkel, S., Gauthier, S., Levy, R., Mallery, L., Reisberg, B., Schneider, L., & Billington, R. (1996). Round table discussion: The clinician's view on outcome methodologies for pharmacologic trials in mild, moderate, and severe Alzheimer's disease. International Psychogeriatrics, 8(2), 335-342. https://doi.org/10.1017/S1041610296002694

Mina Bergem, AL, Burns, A, Eriksson, S, Finkel, S, Gauthier, S, Levy, R, Mallery, L, Reisberg, B, Schneider, L & Billington, R 1996, 'Round table discussion: The clinician's view on outcome methodologies for pharmacologic trials in mild, moderate, and severe Alzheimer's disease', International Psychogeriatrics, vol. 8, no. 2, pp. 335-342. https://doi.org/10.1017/S1041610296002694

@article{67bef1161bbe44ecaec8ebf09cd5a262,

title = "Round table discussion: The clinician's view on outcome methodologies for pharmacologic trials in mild, moderate, and severe Alzheimer's disease",

author = "{Mina Bergem}, {A. L.} and A. Burns and S. Eriksson and S. Finkel and S. Gauthier and R. Levy and L. Mallery and B. Reisberg and L. Schneider and R. Billington",

year = "1996",

doi = "10.1017/S1041610296002694",

language = "English",

volume = "8",

pages = "335--342",

journal = "International Psychogeriatrics",

issn = "1041-6102",

publisher = "Cambridge University Press",

number = "2",

}

TY - JOUR

T1 - Round table discussion

T2 - The clinician's view on outcome methodologies for pharmacologic trials in mild, moderate, and severe Alzheimer's disease

AU - Mina Bergem, A. L.

AU - Burns, A.

AU - Eriksson, S.

AU - Finkel, S.

AU - Gauthier, S.

AU - Levy, R.

AU - Mallery, L.

AU - Reisberg, B.

AU - Schneider, L.

AU - Billington, R.

PY - 1996

Y1 - 1996

UR - http://www.scopus.com/inward/record.url?scp=0030465569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030465569&partnerID=8YFLogxK

U2 - 10.1017/S1041610296002694

DO - 10.1017/S1041610296002694

M3 - Article

AN - SCOPUS:0030465569

SN - 1041-6102

VL - 8

SP - 335

EP - 342

JO - International Psychogeriatrics

JF - International Psychogeriatrics

IS - 2

ER -

Round table discussion: The clinician's view on outcome methodologies for pharmacologic trials in mild, moderate, and severe Alzheimer's disease

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Cite this